Lucy Mccarthy is a Senior Manager in Clinical Trial Cost Forecasting at Eli Lilly and Company, where they have been contributing since 2023. Prior to this role, Lucy worked at NAB as a Managed Funds Associate and held various positions, including Global Transparency Data Analyst and Manager of Global Transparency Data Intelligence at Eli Lilly from 2019 to 2022. Lucy earned a Diploma in Financial Services from the Investment Banking Institute Business School and holds both a Master of Business Studies in Economics and a Bachelor of Commerce from University College Cork. Additionally, they are currently affiliated with CPA Australia.
This person is not in the org chart
This person is not in any teams
This person is not in any offices